Omkar Pharmachem Ltd manufactures chemicals used in pharmaceuticals.Product Profile: a) Sodium bi-sulphite b) Sodium meta bi-sulphite c) Sodium sulphite d) Sulphur e) Specialty chemicals f) Ciba specialty chemicals g) Organic chemicals
Omkar Pharmachem has announced its 31st Annual General Meeting (AGM) will be held at Hotel Kanak, Ahmedabad, at 10:30 a.m. The Annual Report for the financial year 2025-26 has been sent electronically to shareholders. The company provides remote e-voting, opening September 27 at 9:00 a.m. and closing September 29 at...
Omkar Pharmachem Limited has announced the publication of its financial results for the quarter ended June 30, 2026. These results have been made public through advertisements in both vernacular and English newspapers. This disclosure provides crucial insight into the company's recent operational and financial performance, enabling shareholders and potential investors...
Omkar Pharmachem has announced a special window for the transfer and dematerialization of physical shares. This initiative offers a crucial opportunity for shareholders currently holding their shares in physical certificates to convert them into electronic (demat) form. The company has publicized this update through newspaper advertisements in both vernacular and...
Omkar Pharmachem Limited announced that its Registrar and Share Transfer Agent has confirmed the efficient processing of all requests for converting physical shares into digital form. This ensures that all such securities were properly handled, confirmed to depositories, and listed on the stock exchanges. Physical certificates were meticulously cancelled after...
Omkar Pharmachem Limited has received a compliance certificate from its Registrar and Share Transfer Agent for the quarter ending June 30. This certificate confirms that all securities received for dematerialization during the period were processed correctly, accepted or rejected, and subsequently listed on the stock exchanges. It further verifies that...
